Coronavirus Chaos Makes These 2 Healthcare Dividend Aristocrats Look Good

Healthcare is one of the few sectors seeing high demand right now, with companies working to develop COVID-19 vaccines, treatments, and diagnostic tests. The sector also offers its fair share of volatility, however. So for investors seeking stability and income during the pandemic, these two healthcare Dividend Aristocrats should be a good choice in the chaos.

Who isn't familiar with Johnson & Johnson's (NYSE:JNJ) brands? Listerine, Neutrogena, Clean & Clear, Benadryl, Stayfree, and many more are staples in consumers' lives. As a Dividend Aristocrat, Johnson & Johnson has grown its adjusted operating earnings for 35 years. As a cherry on top, it's consistently increased its dividend payments to shareholders for the past 58 years. Just like Johnson & Johnson, Medtronic (NYSE:MDT) is a Dividend Aristocrat that has increased its payouts for the past 42 years. An Ireland-based medical device manufacturer, Medtronic's current dividend yield isn't sky-high at just 2.2%, but its capacity to increase that dividend makes it an exciting stock in these distressing times. In March, the company announced an 8% dividend increase for fourth-quarter 2020.

Source: Motley Fool

Related Articles:
- 7 High Yield, High Risk Dividend Securities
- 5 Dividend Stocks To Buy And Hold, Not Buy And Forget
- International Diversification May Be Closer than You Think
- Warren Buffett's Two Investing Rules For Dividend Investors
- Dividend Stocks vs. Dividend ETFs